Atrae, Inc. Logo

Atrae, Inc.

Develops People Tech solutions for HR, including big data job sites and organizational analytics.

6194 | T

Overview

Corporate Details

ISIN(s):
JP3121890002
LEI:
Country:
Japan
Address:
港区麻布十番1−10−10
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Atrae, Inc. is a technology company that defines its business domain as “People Tech,” with a mission to create services that expand human potential. The company develops and manages IT solutions primarily for the Human Resources sector. Its portfolio includes contingent fee-based job websites that leverage big data to connect talent with opportunities. A key product is Wevox, a platform designed to analyze organizational health and improve corporate value, which is also offered through a joint venture with SMBC Group. Atrae also operates in the "Sports Tech" segment, consistently aiming to build businesses that attract people worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-14 09:46
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 26.2 KB
2025-09-12 08:55
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.8 KB
2025-05-14 08:05
Interim Report
半期報告書-第22期(2024/10/01-2025/09/30)
Japanese 166.2 KB
2025-05-14 08:05
Report Publication Announcement
確認書
Japanese 8.0 KB
2025-04-14 09:06
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.8 KB
2025-03-13 08:50
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.7 KB
2025-02-03 08:20
Share Issue/Capital Change
訂正臨時報告書
Japanese 37.7 KB
2025-01-14 07:16
Regulatory News Service
臨時報告書
Japanese 39.6 KB
2025-01-14 07:14
Regulatory News Service
臨時報告書
Japanese 29.8 KB
2024-12-23 01:58
Post-Annual General Meeting Information
臨時報告書
Japanese 21.8 KB
2024-12-19 02:05
Regulatory News Service
確認書
Japanese 8.0 KB
2024-12-19 02:04
Regulatory News Service
内部統制報告書-第21期(2023/10/01-2024/09/30)
Japanese 21.6 KB
2024-12-19 02:03
Annual Report
有価証券報告書-第21期(2023/10/01-2024/09/30)
Japanese 985.6 KB
2024-11-14 08:08
Earnings Release
臨時報告書
Japanese 18.2 KB
2024-10-11 08:52
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.5 KB

Automate Your Workflow. Get a real-time feed of all Atrae, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Atrae, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Atrae, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AngioLab, Inc. Logo
Develops anti-angiogenic therapeutics and foods for angiogenesis-related diseases.
South Korea 251280
Anixa Biosciences Inc Logo
Clinical-stage biotech developing CAR-T immunotherapies and vaccines to fight cancer.
United States of America ANIX
Annovis Bio, Inc. Logo
Developing oral therapies for neurodegenerative diseases like Alzheimer's and Parkinson's.
United States of America ANVS
Aoyama Zaisan Networks Company,Limited Logo
Consulting on inheritance and business succession for individuals and corporations.
Japan 8929
APG SGA SA Logo
Switzerland's leading OOH media firm offering digital and analogue outdoor advertising solutions.
Switzerland APGN.SW
Biotech R&D using a miniature pig model, offering CRO services and biomaterials to pharma.
South Korea 149300
ARM HOLDINGS PLC /UK Logo
Licenses energy-efficient CPU IP for AI, mobile, automotive, IoT, and cloud markets.
United States of America ARM
Arterra Bioscience Logo
Develops natural active ingredients via biotechnology for cosmetic, pharma, and food sectors.
Italy ABS
ARVINAS, INC. Logo
Develops protein degradation drugs for oncology & neuroscience, targeting undruggable proteins.
United States of America ARVN
ASUA Inc. Logo
Consulting and solutions provider enhancing logistics safety and efficiency with IoT and telecom.
Japan 246A

Talk to a Data Expert

Have a question? We'll get back to you promptly.